<DOC>
	<DOCNO>NCT01289977</DOCNO>
	<brief_summary>Sand fly carry infection leishmaniasis ( parasite ) . The purpose study evaluate human immune response uninfected laboratory raise sand fly bite select immune response sand fly saliva , possible substance use future vaccine protect parasite leishmaniasis .</brief_summary>
	<brief_title>Immune Responses After Human Subject Challenge With Sand Fly Bites</brief_title>
	<detailed_description>Based travel history possible exposure , subject enter one 2 arm , Ph . dubosqui Lu . lutzomyia control sand fly repeat feeding . At baseline pheresis do collect baseline cell . Subjects receive sand fly bite q2 week schedule 2 month follow q2 month schedule one year . They option extend late recall feed 18 month , skin biopsy perform 48 hour sand fly bite . Currently study fully enrol human subject contact complete . We ( laboratory NIAID ) study humoral , cellular immune response use blood sample , cytokine expression skin biopsy sample .</detailed_description>
	<criteria>Age 1850 Plans remain DC area least one year willingness participate study procedures general good health military health care beneficiary able provide inform consent Prior travel geographic area leishmania transmit sand fly common positive antibody sand fly saliva screen blood test pregnancy elevate serum IgE history chronic medical illness adult history treatment require anemia large reaction insect bite history multiple vasovagal reaction phlebotomy difficult venous access phlebotomy Taking medication could interfere immune response</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Sandfly</keyword>
	<keyword>leishmaniasis</keyword>
	<keyword>immune response</keyword>
	<keyword>individual age 18-50</keyword>
</DOC>